Department of Public Affairs

3400 Spruce St.
Philadelphia, PA 19104-6021


Media Contact:

(for this release

Ellen O'Brien

(215) 349-5653

July 14, 2003

Laura Demopoulos, MD, Joins UPHS As Director of the Women's Heart Program

(Philadelphia, PA) -- Laura A. Demopoulos, MD, has been appointed Clinical Associate Professor of Medicine in the Cardiovascular Medicine Division of the University of Pennsylvania School of Medicine, and Director of the Women's Heart Program for the University of Pennsylvania Health System. She will practice at PENN Medicine at Radnor, effective immediately.

"Dr. Demopoulos brings to Penn a practiced hand in patient care as well as extensive experience in clinical trials and patient-oriented research, and we are delighted she has agreed to serve as Director of our expanding Women's Heart Program in the Division," said Michael S. Parmacek, MD, Chief of the Cardiovascular Division in Penn's School of Medicine.

Demopoulos, a board-certified physician in internal medicine and cardiovascular diseases, comes to Penn from Merck and Co., Inc, where she was Executive Director of the pharmaceutical company's Cardiovascular Research Department. She has also served for the past six years as an attending physician in the Cardiology Fellows Clinic at the Hospital of the University of Pennsylvania (HUP), and prior to that served as an attending physician at Albert Einstein Medical School in New York.

She earned her medical degree from New York University and completed her internship, residency, Chief Residency and fellowship at New York University Medical Center. She did research in heart failure at Albert Einstein College of Medicine in New York before joining Merck. Demopoulos has held teaching positions at the Massachusetts Institute of Technology and at New York University Medical Center and Albert Einstein. She has conducted extensive research in the field of cardiology and has contributed to more than 60 published research articles.

At PENN Medicine at Radnor, Demopoulos is building a multi-disciplinary team that offers medical care designed to address the specific needs of women in treating and preventing heart disease.

"Women have a different onset of symptoms and different risk factors than men, and so we are creating a program designed especially for women's cardiovascular health," Demopoulos said.

All heart patients have access to electrophysiologists; preventive and interventional cardiologists; and heart-failure and transplant specialists at PENN Medicine at Radnor. The comfortable, suburban facility also offers a complete range of cardiac diagnostic services, including electrocardiograms; exercise stress testing; exercise stress cardiography; echocardiography; nuclear imaging; treatment and consultation related to pacemakers and implantable defibrillators; and Holter and cardiac event monitoring.


Editor's note: You may also find this news release online at www.uphs.upenn.edu

PENN Medicine is a $2.2 billion enterprise dedicated to the related missions of medical education, biomedical research, and quality patient care. PENN Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System (created in 1993 as the nation's first integrated academic health system). Penn's School of Medicine is ranked #2 in the nation for receipt of NIH research funds; and ranked #4 in the nation in U.S. News & World Report's most recent ranking of top research-oriented medical schools. Supporting 1400 fulltime faculty and 700 students, Penn's School of Medicine is recognized worldwide for its superior education and training of the next generation of physician/scientists and leaders of academic medicine. Penn's Health System consists of four hospitals (including its flagship Hospital of the University of Pennsylvania, consistently rated one of the nation's "Honor Roll" hospitals by U.S. News & World Report); a faculty practice plan, a primary-care provider network, three multispecialty satellite facilities, and home healthcare and hospice.




Press Releases




Events & Calendars



Privacy Policy Disclaimer Terms of Use